SONIRE Therapeutics Inc.

Biotechnology company · Palo Alto, California, United States

SONIRE Therapeutics Inc. is a biotechnology company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

SONIRE Therapeutics at a glance

Typebiotechnology company

HeadquartersPalo Alto, California, United States

Earliest incorporation on record2025

SEC CIK2129660

What does SONIRE Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $13.5 million sold (2026).

Frequently asked questions about SONIRE Therapeutics

Where is SONIRE Therapeutics headquartered?

SONIRE Therapeutics Inc. is headquartered in Palo Alto, California, United States.

What does SONIRE Therapeutics do?

SONIRE Therapeutics Inc. is a biotechnology company.

When was SONIRE Therapeutics founded?

The earliest incorporation on record for SONIRE Therapeutics Inc. is in 2025, according to public company registers.

Similar companies

Exai Bio Inc.Palo Alto, California, United States
Kodiak Sciences Inc.Palo Alto, California, United States
Scilex Holding CoPalo Alto, California, United States
Immune-Onc Therapeutics, Inc.Palo Alto, California, United States
Greenstone Biosciences, Inc.Palo Alto, California, United States
Combinati IncPalo Alto, California, United States
Eiger BioPharmaceuticals, Inc.Palo Alto, California, United States
Riboscience LLCPalo Alto, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences